Closing the patient care gap in autoimmunity:
The clinical value of new biomarker

Clinicians, laboratorians, and patients have one goal in common - improving healthcare. Autoimmune diseases are challenging to diagnose due to the seronegative gap, often leading to delays in treatment for the patient.

With the development of new biomarkers and technologies, patients can receive a more accurate, earlier diagnosis including valuable information regarding risk stratification. We will discuss new biomarkers for autoimmune disease and present an advanced technology for multi-analyte testing. 


WHEN: Tuesday, August 6th, 2019

TIME: 7:00 - 8:30 am

WHERE: Hilton Anaheim Hotel California Ballroom B, 2nd floor

Come early at 6:45 am and join us for a light breakfast.
Registered attendees are eligible for 1.5 CEU credit.

Speakers & Topics

Meet the experts


Xavier Bossuyt, MD, PhD

Katholeike Universiteit Leuven
Leuven, Belgium

"Meeting the challenges of the modern autoimmune laboratory"


Savino Sciascia, MD, PhD

University of Torino
Turin, Italy

"Clinical journey of the autoimmune patient- new frontiers in closing the seronegative gap and improving risk assessment"


Michael Mahler, PhD

Inova Diagnostics, Inc.
San Diego, CA

"Introduction to a digital multi-analyte system"

AptivaTM* Debut at Autoimmunity Congress in 2018

*Product is in development. Not for sale.